These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7477184)

  • 1. Glucocorticoids and joint destruction in rheumatoid arthritis.
    Porter D
    N Engl J Med; 1995 Dec; 333(23):1569; author reply 1570. PubMed ID: 7477184
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.
    Svensson B; Boonen A; Albertsson K; van der Heijde D; Keller C; Hafström I
    Arthritis Rheum; 2005 Nov; 52(11):3360-70. PubMed ID: 16255010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucocorticoids and joint destruction in rheumatoid arthritis.
    Deodhar AA; Woolf AD
    N Engl J Med; 1995 Dec; 333(23):1569-70. PubMed ID: 7477185
    [No Abstract]   [Full Text] [Related]  

  • 4. Prednisolone in early rheumatoid arthritis: an antiinvasive effect.
    Harris ED
    Arthritis Rheum; 2005 Nov; 52(11):3324-5. PubMed ID: 16255013
    [No Abstract]   [Full Text] [Related]  

  • 5. Joint destruction after glucocorticoids are withdrawn in early rheumatoid arthritis. Arthritis and Rheumatism Council Low Dose Glucocorticoid Study Group.
    Hickling P; Jacoby RK; Kirwan JR
    Br J Rheumatol; 1998 Sep; 37(9):930-6. PubMed ID: 9783756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does modern treatment of early rheumatoid arthritis reduce the need for intra-articular glucocorticoids?
    Weitoft T; Øberg K
    Scand J Rheumatol; 2013; 42(2):163-4. PubMed ID: 23441860
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative study of 2 corticosteroids, in a test of double anonymity, in the treatment of the rheumatoid arthritis].
    da Gama GG; Lucca F; Souto MG; Silva JR
    Hospital (Rio J); 1966 Oct; 70(4):981-90. PubMed ID: 5301493
    [No Abstract]   [Full Text] [Related]  

  • 8. Cholesterol crescents and plates in shoulder effusion of a rheumatoid patient.
    Ho S; Srinivasan U; Bevan M
    Rheumatology (Oxford); 2008 Mar; 47(3):377-8. PubMed ID: 18211948
    [No Abstract]   [Full Text] [Related]  

  • 9. Low disease activity state with corticosteroid may not represent 'true' low disease activity state in patients with rheumatoid arthritis.
    Iikuni N; Inoue E; Tanaka E; Hara M; Tomatsu T; Kamatani N; Yamanaka H
    Rheumatology (Oxford); 2008 Apr; 47(4):519-21. PubMed ID: 18356177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evidence for low-dosage prednisolone in early rheumatoid arthritis. Prevents destruction of the joints and relieves symptoms].
    Svensson B; Hafström I
    Lakartidningen; 2006 Nov 22-28; 103(47):3704-9. PubMed ID: 17212318
    [No Abstract]   [Full Text] [Related]  

  • 11. Combination drug strategy in recent-onset rheumatoid arthritis suppresses collagen I degradation and is associated with retardation of radiological progression.
    Hakala M; Risteli J; Aman S; Kautiainen H; Korpela M; Hannonen P; Leirisalo-Repo M; Laasonen L; Paimela L; Möttönen T;
    Scand J Rheumatol; 2008; 37(2):90-3. PubMed ID: 18415764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Should long-term corticosteroid treatment be given in rheumatoid arthritis?].
    Laroche M; Arlet J
    Rev Rhum Ed Fr; 1993 May; 60(5):317-20. PubMed ID: 8167636
    [No Abstract]   [Full Text] [Related]  

  • 13. Are glucocorticoids DMARDs?
    Bijlsma JW; Hoes JN; Van Everdingen AA; Verstappen SM; Jacobs JW
    Ann N Y Acad Sci; 2006 Jun; 1069():268-74. PubMed ID: 16855154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucocorticoids and joint destruction in rheumatoid arthritis.
    Fries JF; Singh G
    N Engl J Med; 1995 Dec; 333(23):1569; author reply 1570. PubMed ID: 7477183
    [No Abstract]   [Full Text] [Related]  

  • 15. [Corticosteroids for treatment of rheumatoid arthritis].
    Tanaka Y
    Nihon Rinsho; 2005 Jan; 63 Suppl 1():468-71. PubMed ID: 15799401
    [No Abstract]   [Full Text] [Related]  

  • 16. Low dose glucocorticoid therapy in rheumatoid arthritis (RA): transitional or selected add-on therapy?
    Masi AT
    J Rheumatol; 1983 Oct; 10(5):675-8. PubMed ID: 6227745
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges of predicting treatment response in patients with rheumatoid arthritis.
    Smolen JS; Aletaha D
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):62-3. PubMed ID: 16932630
    [No Abstract]   [Full Text] [Related]  

  • 18. Glucocorticoids in rheumatoid arthritis: a senescent research agenda on the brink of rejuvenation?
    Boers M
    Best Pract Res Clin Rheumatol; 2004 Feb; 18(1):21-9. PubMed ID: 15123035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL; Mason JC; Davies KA
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of glucocorticoids in preventing joint destruction: Comment on the review by Schett et al.
    Kirwan JR; Boers Msc M
    Arthritis Rheum; 2009 Apr; 60(4):1202-3; reply 1203-4. PubMed ID: 19333941
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.